Search This Blog

Wednesday, November 6, 2019

FDA OKs Aurobindo’s naloxone for opioid overdose

The FDA has approved Aurobindo Pharma’s (OTC:ARBQY) injectable Naloxone Hydrochloride for the treatment of opioid overdose.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)